INTRODUCTION
Life-threatening bleeding in aortic aneurysm repair is a feared perioperative complication. In open aortic surgery massive blood loss is associated with increased mortality. 1, 2 Endovascular aneurysm repair (EVAR) is an established method of treatment of infrarenal abdominal aortic aneurysms (AAAs) if technically feasible. 3 The method is associated with a lower perioperative blood loss compared to the open approach. 4e6 However, few studies have investigated perioperative bleeding in EVAR and its impact on outcome.
In EVAR visible and measurable bleeding occurs at the femoral or brachial artery access sites. Intra-abdominal bleeding from the aorta, its branches and the iliac arteries can also occur after rupture or by iatrogenic injury. Previous studies have investigated perioperative bleeding related to closure devices and other methods of access site closure. 7e10 The aim of the present study was to evaluate outcome and predisposing factors related to perioperative bleeding in patients treated with both elective and emergent EVARs.
MATERIAL AND METHODS
This was a retrospective cohort study of consecutive patients undergoing EVAR for AAA at the two largest vascular centres in Sweden, Karolinska University Hospital and Malmö Vascular Centre, from 1 April 2008 until 31 August 2011. Patients treated with elective or emergent EVAR were considered for the study. Patients treated for ruptured AAA, obviously being different in their presentation and outcome compared with elective cases, were separately analysed as appropriate. Aneurysm morphology and symptoms decided the treatment method and vascular access route.
Data collection
Data were collected from the Swedish Vascular Registry (Swedvasc), a national registry with high compliance, and local hospital medical records. 11 Incomplete or non-existing data in the registry were obtained from medical records. Preoperative data including demographics, smoking habits, co-morbidities, medical therapy, aneurysm morphology and indication of procedure (elective, symptomatic or ruptured aneurysm) were collected. Blood chemistry data were collected from the hospital's local laboratory data banks.
Data including access route, stent-graft manufacturer, introducer size, number of components and method of closure were retrieved from the operative charts as well as procedure-related information such as methods of anaesthesia, perioperative haemodynamic instability, visualised endoleak and type of endoleak on completion angiography. Procedure time was captured from the local computerised surgery-planning programme (OrbitÔ, EVRY Health & Care AB, Kristianstad, Sweden).
Outcome measures
Primary outcome measures were 30-day mortality, reoperation and conversion to open surgery. Secondary outcome measures were postoperative complications such as myocardial infarction (MI), stroke, respiratory insufficiency and dialysis-dependent renal failure and length of hospital stay.
Perioperative blood loss
The blood loss volume was collected from the operative report, anaesthetist's medical chart and Swedvasc. Perioperative blood loss was estimated from operative lap sponges and volume of blood collected from suction. In ruptured AAA cases with intra-abdominal haemorrhage on computed tomography (CT) and/or signs of ongoing bleeding, the total blood loss was estimated on established measured factors such as haemodynamic parameters (pulse, blood pressure and patient's estimated blood volume), the initial haematocrit and the volume of perioperative fluid requirements and transfusion of blood products. 12, 13 Blood loss was grouped into <1000, 1000e 1999, 2000e4999 and >5000 ml according to practice and standard in Swedvasc. The perioperative bleeding volume was analysed in relation to outcome and preoperative data. Subgroup analysis was performed as appropriate for elective and ruptured groups.
Ethics
The Regional Ethics Committee of Stockholm approved the study.
Statistical analysis
Data analysis was performed using Statistical Package for the Social Sciences (SPSS), version 19.0 (IBM, New York, NY, USA). Descriptive statistics, including means, medians, standard deviations, ranges, interquartile ranges (IQRs) and proportions, were calculated as appropriate. Chi-squared or Fisher's exact tests were used as appropriate to compare nominal variables between groups. Univariable analysis of binary, nominal and ordinate variables was performed. Variables associated with increased blood loss (P < 0.05 in univariable analysis) were analysed in a logistical regression model. Significant relationships were expressed as odds ratio (OR) with 95% confidence interval (CI). P values <0.05 were considered to be statistically significant.
RESULTS

Demographics and pre-, intra-and postoperative descriptive data
A total of 525 patients with AAAs undergoing EVAR were included in the study. A total of 203 patients (28% of all patients treated for AAA) were treated by open aneurysm surgery during the study period and were not considered for the study. Patients lost to follow-up (n ¼ 2; foreign referrals followed up in their home countries) were excluded. Mean age was 73 (46e89) years; 441 (84%) were men. Demographic data are presented in Table 1 .
A total of 382 patients (73%) were elective cases, 53 patients (10%) were symptomatic and 90 (17%) were ruptured AAAs. Conventional EVAR stent grafts were used from Cook Perioperative bleeding related to preoperative and perioperative data A total of 453 of all cases (86.3%) presented a bleeding <1000 ml. Forty-two patients (8%) were reported to have a blood loss between 1000 and 1999 ml, 19 (3.6%) 2000 and 5000 ml and 11 (2.1%) >5000 ml. Data on non-ruptured and ruptured AAA patients are presented in Table 2 .
Co-morbidities, anti-thrombotic medications or preoperative laboratory data were not statistically significantly associated with risk of increased perioperative bleeding.
Open femoral artery access (n ¼ 101), branched (n ¼ 18) and uniiliac (n ¼ 18) endografts, introducer size and aneurysm diameter were all significantly associated with larger perioperative bleeding (P <
Primary open access showed a significantly higher association with increased bleeding compared to percutaneous approach (P < 0.001). For primary open accesses 41 patients out of 101 (40.6%) presented a perioperative bleeding of >1000 ml (P < 0.001). Twenty-eight patients out of 263 (10.6%) who underwent FS had perioperative bleeding >1000 ml. Three out of 159 (1.9%) patients undergoing closure with PS bled >1000 ml. Data are presented in Table 3 .
Outcome related to perioperative bleeding
The 30-day mortality rate was 0.8% (3/382) in elective patients and in symptomatic and ruptured AAA patients 5.5% (3/53) and 21% (19/90), respectively. At 30-day followup a total complication rate of 22.8% (n ¼ 120/525) was reported, including re-operation for bleeding 23 (4.4%), postoperative MI 9 (1.7%), renal insufficiency 19 (3.6%), multi-organ failure (MOF) 13 (2.5%), graft occlusion 5 (1%), endoleak 15 (2.9%) and abdominal compartment syndrome (ACS) 10 (1.9%). Among other complications reported were cerebrovascular insult (n ¼ 4), venous injuries after FS (n ¼ 2), covered renal artery (n ¼ 4), postoperative septicaemia (n ¼ 2), iliac artery dissection (n ¼ 2), iliac artery rupture (n ¼ 1), pseudo-aneurysm brachial artery (n ¼ 1), total dislocation of main body stent graft into aneurysm sac (n ¼ 1) and aortoenteric fistula (n ¼ 1). Table 3 . Perioperative variables related to bleeding volume. Age >80 years, s-creatinine >120, aneurysm diameter >70 mm, ruptured AAA and perioperative bleeding >2000 ml were significantly associated with 30-day mortality (P < 0.01) in univariable logistic regression analysis of pooled data from all patients. In multivariable logistic regression analysis, only ruptured AAA and perioperative bleeding >2000 ml were significantly associated with 30-day mortality (OR 10.6 (95% CI 3.8e29.6) and OR 13.4 (95% CI 4.8e37.4), respectively). Data are presented in Table 4 .
Multivariable logistic regression analysis in the ruptured group showed that perioperative bleeding >2000 ml was significantly associated with increased mortality (OR 10.68 (95% CI 3.2e36.1)) P < 0.001.
Also in the non-ruptured group, although few events, perioperative bleeding of >2000 ml (n ¼ 11) was significantly associated with 30-day mortality (n ¼ 6) (OR 30 (95% CI 3.6e145)) P ¼ 0.001.
In non-ruptured and ruptured AAA cases (separately analysed), postoperative renal failure, MOF, >5 day stay in intensive care unit (ICU), bowel ischaemia and ACS were all postoperative complications significantly related to perioperative bleeding in the multivariable analysis (P < 0.001). Data are presented in Tables 5a and b . Other complications such as MI, cerebrovascular insult, re-operation, endoleak and overall mean length of hospital stay were not significantly related to bleeding volume.
DISCUSSION
An advantage of EVAR compared to open approach is the decreased perioperative bleeding, 200e400 ml versus 1000e1500 ml in elective cases.
4e6, 14 Blood loss in elective EVAR is most commonly a result of leakage from guide wire and sheath exchanges and from complications during access site closure.
To our knowledge no previous study has evaluated outcome related to perioperative bleeding in acute and elective EVARs. This study has shown that perioperative blood loss exceeding 2 l, in patients treated with EVAR for ruptured AAA, increases 30-day mortality rate. In multivariable analysis of the total patient cohort, perioperative bleeding exceeding 2 l showed a stronger correlation to mortality than ruptured AAA. This might be explained by the observation that patients with a contained rupture, without ongoing bleeding and need of massive transfusions, often recover fast if there is no perioperative bleeding complication. The few elective patients with blood loss exceeding 2 l limit conclusions about the danger of large bleedings in this group. Elective patients with a perioperative blood loss >2 l showed a significant increase in postoperative complications.
Our data suggest that perioperative blood loss is not associated with co-morbidities or preoperative blood chemistry and coagulation data. Most often it seems to relate to technical issues, such as open femoral artery approach and access site closure problems.
Other risk factors for increased perioperative bleeding related to technical factors were large-diameter introducers, which concurs with previous studies, and branched EVAR. 8, 15 In branched EVAR, large-diameter introducers are often used and these procedures tend to be longer which might explain why branched EVARs tend to bleed more. However, procedure time per se was not related to larger bleeding.
The safety of different methods of access site closure has previously been analysed. 7e10, 16 Excellent results for a closure device (double ProStarXL Ò ) used off-label for larger introducer sizes than 18 Fr and FSs have been reported with failure rates of 2e10%. 16, 17 In this study, FSs and closure devices were equally good in obtaining haemostasis.
Massive blood loss, in open aortic surgery, is an independent risk factor associated with increased mortality 1,2 This study, limited by its retrospective nature, includes the EVAR experience from two centres with both conventional and more advanced reconstructions. Our 30-day mortality rates for elective and ruptured cases are comparable to previous studies. 6, 18 In patients undergoing EVAR for ruptured AAA, the internal blood volume loss is difficult to estimate.This is a limitation of this study. We based our estimation of the perioperative blood loss on established factors including haemodynamic parameters and blood transfusion requirements. However, it is well known that, in surgical procedures in general, the perioperative estimated blood loss is both poorly reproducible and usually underestimated. 12 It may be possible to estimate the volume of the retroperitoneal or intraabdominal haematoma using CT and three-dimensional (3D)-volume rendering techniques, but this has not been established in AAA studies. 19 The 3D-volume rendering techniques have previously been used in calculating volume of cerebral haematomas as a predictor for outcome. 20 In conclusion, large perioperative haemorrhage during EVAR is a clinical problem that affects outcome. Efforts must be made to minimise perioperative blood loss. About 10% of elective AAA patients and 34% of patients with ruptured AAA, undergoing EVAR, present a perioperative blood loss exceeding 1 l. In our study, a perioperative blood loss exceeding 2 l was independently associated with increased mortality and morbidity in both acute and elective AAA patients. Open femoral access, branched EVAR and larger-diameter introducers were associated with increased perioperative blood loss. 
